Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-progestin breast cancer prevention study 1
ISRCTN15575894Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of ulipristal in breast cancer, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Change in Ki67 proliferation. Started Sep 2015; status: completed.
02
Drugs
ulipristal
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN15575894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15575894.